Clinical Trial

Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal microbiome. FMT has a higher cure rate than standard antibiotic treatment for recurrent Clostridium difficile infections,and shows promising results in Inflammatory bowel disease(IBD).However, few studies have evaluated whether FMT is effective to treat Irritable bowel syndrome(IBS).The investigators propose to determine the efficiency and safety of FMT in patients with Irritable bowel syndrome.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2018-08-01; most recent amendment 2021-08-01.
Trial Details
NCT Number NCT03613545
Lead Sponsor Guangzhou First People's Hospital
Conditions Irritable Bowel Syndrome, Fecal Microbiota Transplantation
Enrollment 120 participants
Start Date 2018-08-10
Primary Completion 2028-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-08-03